Recent Antiphospholipid Syndrome News:
- Ginger shows promise as a natural defense against autoimmune diseases
- Ginger Supplements May Benefit People With Autoimmune Diseases | TheHealthSite.com
- Ginger supplements show promise in reducing autoimmune conditions – Medical Dialogues
- Are Cellular Therapies the Future of Autoimmune Disease? – Medscape
- Squalene Market Size, Share, Growth, Report 2023-2028 – Digital Journal
- New Study Examines the Benefits of Ginger Supplements in Autoimmune Diseases Like Lupus
- The Role of Ginger in Controlling Inflammation for Autoimmune Disease Sufferers: A Critical Find
- A Successful Pregnancy Outcome After Continued Surveillance of Lupus Anticoagulant … – Cureus
- Ginger supplement boosts white blood cell resilience, study suggests
- Cureus | Successful Renal Transplantation in a Patient With Senior-Loken Syndrome and …
- Ginger Supplements May Help With Autoimmune Disorders Like Lupus – Healthline
- Can Ginger Supplements Help In Treating Autoimmune Disorders? Study Says They …
- Ginger supplements can be beneficial in treating autoimmune diseases: Study – Siasat.com
- Mind, Body & Heart – Bangalore Mirror
- New study finds ginger plays critical role in controlling inflammation for those with … – Bristol Live
- Ginger May Help Reduce Inflammation in Autoimmune Diseases – Everyday Health
- New Research Adds Evidence to the Benefits of Ginger Supplements for Treating …
- Ginger Consumption May Mitigate Neutrophil Dysfunction – Medscape
- New research adds evidence to the benefits of ginger supplements for treating autoimmune diseases
- Ginger supplements pack anti-inflammatory punch that may knock out autoimmune diseases
- Autoimmune diseases: Ginger supplements may help manage inflammation
- Nutritional Supplement That Can Help You Reverse and Prevent Inflammation Linked to … – Revyuh
- Health benefits of ginger as new study says it can help people living with autoimmune diseases
- ‘Don’t give up’: Catatonic woman wakes up after 20 years following treatment for lupus
- Acute Stroke at Term Pregnancy: What Should Happen Before the Epidural? – Cureus
- Lower Risk of Recurrent VTE With Direct Oral Anticoagulants vs Warfarin During Extended …
- Anti Phospholipid ELISA Kit Market to Witness Massive Growth by 2029 – Laguna Now
- ‘The elephant in the room’: Age, disease-related factors may drive JAK safety signals
- 2023 ACR/EULAR Antiphospholipid Syndrome Classification Criteria
- An Unusual Case of Nonbacterial Thrombotic Endocarditis Attributable to Malignancy
- Cadrenal Therapeutics Highlights Additional Need for a New Vitamin K Antagonist …
- Antiphospholipid Syndrome Market Analysis, Overview and Industry Trends 2023-2033
- Introducing Tecarfarin A Breakthrough Oral Anticoagulant for Rare Medical Conditions
- Development and implementation of a continuing care program for patients with intellectual …
- Rozanolixizumab: First Approval. – Physician’s Weekly
- Primary Antiphospholipid Syndrome and its Association with Heart Valve Disease
- Efforts to Better Characterize “Antiphospholipid Antibody Nephropathy” for the 2023 ACR …
- FDA approves Ilaris for the treatment of gout flares in adults – Healio
- Patients with COVID-19 have 43% increased risk for new-onset autoimmune diseases
- Other news to note for Aug. 30, 2023 – BioWorld
- Osteoarthritis expected to impact nearly 1 billion people by 2050 – Healio
- BioVaxys and The Ohio State University Extend Research Collaboration – InvestorsObserver
- Cadrenal Therapeutics Expands Evaluation of Tecarfarin for Patients with Antiphospholipid …
- Novel autoantibodies implicated in pregnancy disorders – Medical Xpress
- CAR T cells in autoimmunity: A potential breakthrough about to explode – Healio
- Sandoz concludes acquisition of Mycamine antifungal agent from Astellas
- Predictive Tools for Thrombosis Recurrence in Antiphospholipid Syndrome Demonstrate …
- A nurse’s view: Blood test for severe preeclampsia will save lives | MDedge ObGyn
- Disentangling long COVID from fibromyalgia: Patients often feel ‘disrespected, ignored’
- New-onset inflammatory diseases ‘may be triggered’ by COVID-19 infection, vaccination
Antiphospholipid Syndrome News:
- Nine research updates in thrombosis treatment, surveillance and risk prediction.
-
Antiphospholipid syndrome. This review summarizes the main knowledge on the clinical and therapeutic aspects of this syndrome.
-
Antiphospholipid syndrome: frequency, main causes and risk factors of mortality. Thrombotic complications are the most common cause of death in APS.
-
Heart attack: New finding may change the face of treatment
-
Hughes syndrome (antiphospholipid syndrome) and the nervous system.
-
When autoimmune diseases exert neuro-ophthalmic effects
-
Catastrophic antiphospholipid syndrome: The current management approach.
- 2016 review on catastrophic antiphospholipid syndrome.
-
Pregnancy and APS: Results Look Encouraging
-
The Role of Viral Infections and Vaccines in the Pathogenesis of Antiphospholipid Syndrome
-
Anticoagulating patients with high-risk acquired thrombophilias.
-
Infectious, Noninfectious Postoperative Complications More Frequent in Patients With SLE
-
Catastrophic antiphospholipid syndrome: The current management approach.
- Rapidly progressive coronary artery disease as the first manifestation of antiphospholipid syndrome. case report
- C-sections raise blood clot risk; protection urged in new recommendation from American College of Obstetricians and Gynecologists. CBS News,
- Myasthenia gravis is sometimes found in conjunction with antiphospholipid syndrome with: A case report
- Primary antiphospholipid syndrome should be considered as a possible cause of repeated stent thrombosis. Journal of Cardiology Cases.
- Good news for prospective mothers with antiphospholipid syndrome? – Journal of Postgraduate Medicine
- New study suggests that long-term anticoagulation with low molecular weight heparin (LMWH) may be a safe and effective alternative for APS patients who had not responded to warfarin (Coumadin) – Annals of Rhematic Diseases
- Rheumatologist Dr. Doruk Erkan talks about Antiphospholipid Syndrome (APS), the disorder that caused my stroke, in this Q&A with the Hospital for Special Surgery. Read it to learn more about APS. – Dr. Doruk Erkan, Rheumatologist
- Preeclampsia: New Research Reveals Why Preeclampsia More Likely For Some Women – Mattason’s Review